Actively Recruiting

Age: 18Years - 90Years
All Genders
Healthy Volunteers
NCT05621837

Quantifying Systemic Immunosuppression to Personalize Cancer Therapy

Led by Fondazione IRCCS Istituto Nazionale dei Tumori, Milano · Updated on 2025-05-02

1000

Participants Needed

1

Research Sites

251 weeks

Total Duration

On this page

AI-Summary

What this Trial Is About

The Serpentine (Stratify cancER PatiENTs by ImmuNosupprEssion) project, represents the most consistent effort so far attempted to translate MDSC into clinical practise by producing an off-the-shelf compliant assay for quantifying these cells in peripheral blood.

CONDITIONS

Official Title

Quantifying Systemic Immunosuppression to Personalize Cancer Therapy

Who Can Participate

Age: 18Years - 90Years
All Genders
Healthy Volunteers

Eligibility Criteria

Eligible

You may qualify if you...

  • Histologically documented diagnosis of metastatic or locally advanced melanoma, hormone-refractory breast cancer, renal cell carcinoma, urinary bladder cancer, squamous cell carcinoma of the head and neck, small cell carcinoma, or non-small cell lung cancer; stage III resectable NSCLC also included
  • Willingness and ability to comply with the study protocol
  • Willingness and ability to provide an adequate archival Formalin-Fixed Paraffin-Embedded (FFPE) tumor sample for exploratory biomarker analysis
  • Age between 18 and 90 years at the time of recruitment
  • ECOG Performance Status of 2 or lower
  • Understanding and signing of informed consent
  • Agreeing to participate in the socio-economic and psychological survey
Not Eligible

You will not qualify if you...

  • Known history of HIV infection
  • Serious neurological or psychiatric disorders
  • Pregnancy or lactation
  • Inability or unwillingness to provide written informed consent
  • Inability or unwillingness to be regularly followed up at the same center

AI-Screening

AI-Powered Screening

Complete this quick 3-step screening to check your eligibility

1
2
3
+1

Trial Site Locations

Total: 1 location

1

Fondazione IRCCS Istituto Nazionale dei Tumori

Milan, Italy, 20033

Actively Recruiting

Loading map...

Research Team

L

Licia Rivoltini

CONTACT

P

Paola Frati

CONTACT

How is the study designed?

Study Type

OBSERVATIONAL

Masking

N/A

Allocation

N/A

Model

N/A

Primary Purpose

N/A

Number of Arms

6

Not the Right Trial for You?

Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.

Already have an account? Log in here